Claritev Corporation (CTEV) News
Follow Claritev Corporation (CTEV) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 28 public stories across 15 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Claritev Reports Q3 2026 Revenue Growth, Updates Guidance
Claritev reported third-quarter revenue of $268.3 million, up 9.1% year over year, and a net loss of $61.8 million. Adjusted EBITDA rose 4.4% to $162.0 million. The company updated its 2026 guidance and issued an initial
EQUITY | Nov 09, 2026, 02:03 PM UTC
M
Claritev Beats Q3 Revenue Estimates, Raises Forecast
EQUITY | Nov 09, 2026, 11:08 AM UTC
M
Claritev Reports Third-Quarter 2026 Results
Claritev reported results for the quarter ended September 30, 2026.
EQUITY | Nov 09, 2026, 11:02 AM UTC
M
Claritev Reports Q3 Revenue of USD 268.311 Million
Claritev reported Q3 net income of USD -61.789 million.
EQUITY | Nov 09, 2026, 11:01 AM UTC
M
CTEV Q3'26 Earnings Preview: EPS Estimated at (3.63) USD
Claritev is scheduled to report Q3'26 results on November 09 before the market opens. Revenue is estimated at 256.13 million USD, with EPS anticipated at (3.63) USD.
EQUITY | Nov 06, 2026, 12:00 PM UTC
M
Vale Profit Falls 53%
Vale reported a 53% decline in profit.
EARNINGS | Oct 30, 2026, 03:42 PM UTC
M
Multiplan Reports Net Profit in Third Quarter
Multiplan reported a net profit in 3Q26, up year over year.
EARNINGS | Oct 29, 2026, 10:42 PM UTC
L
CTEV - Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program
CTEV - Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program
NEWS | Sep 22, 2026, 01:08 PM UTC
L
CTEV - Claritev Releases 2025 Corporate Responsibility Report
CTEV - Claritev Releases 2025 Corporate Responsibility Report
NEWS | Sep 17, 2026, 01:11 PM UTC
L
CTEV: Aggressive tech transformation and market expansion drive robust growth and AI-powered innovation
Healthcare costs and regulatory complexity drive demand for access, protection, and efficiency solutions. Strategic transformation and technology modernization have led to five quarters of growth, with strong bookings, n
NEWS | Sep 15, 2026, 03:00 PM UTC
L
CTEV: AI-driven growth, new markets, and tech transformation position for $1B revenue and future expansion
Healthcare cost pressures and regulatory complexity drive demand for transparency and efficiency, fueling growth through new markets, AI-driven modernization, and product innovation. Bookings and revenue are rebounding,
EARNINGS | Sep 15, 2026, 02:18 PM UTC
L
Claritev appoints Ben Letham to Board and Risk Committee following John Prince's passing
Claritev appointed Ben Letham to its Board as a Class I director and to the Risk Committee, effective September 14, 2026, filling the vacancy created by John Prince's passing.Original SEC Filing: Claritev Corp [ CTEV ] -
REGULATION | Sep 15, 2026, 01:14 PM UTC
L
CTEV - Claritev Appoints Ben Letham to its Board of Directors
CTEV - Claritev Appoints Ben Letham to its Board of Directors
NEWS | Sep 15, 2026, 01:05 PM UTC
L
CTEV - Claritev Cares Helps Rural Patients Get Critical Care Closer to Home
CTEV - Claritev Cares Helps Rural Patients Get Critical Care Closer to Home
EQUITY | Sep 10, 2026, 01:04 PM UTC
L
Claritev Cares Helps Rural Patients Get Critical Care Closer to Home
Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable and transparent for all, today announced that Claritev Cares, its nonprofit foundation f
EQUITY | Sep 10, 2026, 01:01 PM UTC
L
CTEV - Claritev Corporation Announces Participation in Upcoming Events
CTEV - Claritev Corporation Announces Participation in Upcoming Events
EQUITY | Aug 27, 2026, 12:04 PM UTC
L
Claritev Corporation Announces Participation in Upcoming Events
Claritev Corporation Announces Participation in Upcoming Events
EQUITY | Aug 27, 2026, 12:00 PM UTC
L
Marpai expands Claritev relationship to help cut healthcare costs
CTEV discloses Marpai expands its relationship with Claritev, aiming to help reduce healthcare costs for employer clients.
REGULATION | Aug 17, 2026, 01:10 PM UTC
L
Claritev Analysts Raise Their Forecasts Following Q2 Earnings
Claritev Corp (NYSE: CTEV ) on Friday reported better-than-expected second-quarter financial results and raised its FY26 sales guidance above estimates. Claritev reported quarterly losses of $3.49 per share which beat th
EARNINGS | Aug 10, 2026, 02:45 PM UTC
L
Claritev Raises FY2026 Sales Guidance from $985.000M-$1.000B to $1.000B-$1.020B vs $993.511M Est
Claritev (NYSE: CTEV ) raises FY2026 sales outlook from $985.000 million-$1.000 billion to $1.000 billion-$1.020 billion vs $993.511 million estimate.
EARNINGS | Aug 07, 2026, 09:57 AM UTC
L
CTEV - Claritev Demonstrates Market Leadership as Federal No Surprises Act Disputes Reach Record Levels
CTEV - Claritev Demonstrates Market Leadership as Federal No Surprises Act Disputes Reach Record Levels
EQUITY | Jul 30, 2026, 01:06 PM UTC
H
Sector Update: Healthcare Stocks Fall Late Afternoon
() -- Healthcare stocks fell late Tuesday afternoon with the NYSE Healthcare Index declining 1.7% and the State Street Health Care Select Sector SPDR ETF (XLV) dropping 1.9%. The iShares Biotechnology ETF (IBB) shed 0.4%
EARNINGS | Jul 14, 2026, 07:46 PM UTC
L
DOJ Expands Antitrust Probe Into Claritev
() -- (Updates with Claritev's response in the fourth paragraph.) The US Justice Department recently sent civil investigative demands, which are similar to subpoenas, to lawyers for a group of hospitals and doctor groups
GEOPOLITICS | Jul 14, 2026, 07:13 PM UTC
L
DOJ Expands Antitrust Probe Into Claritev
() -- (Update with the Justice Department's response to a request for comment in the third paragraph.) The US Justice Department recently sent civil investigative demands, which are similar to subpoenas, to lawyers for a
GEOPOLITICS | Jul 14, 2026, 05:53 PM UTC
H
Sector Update: Healthcare Stocks Fall Tuesday Afternoon
() -- Healthcare stocks were lower Tuesday afternoon, with the NYSE Healthcare Index down 1.6% and the State Street Health Care Select Sector SPDR ETF (XLV) falling 1.8%. The iShares Biotechnology ETF (IBB) was fractiona
EARNINGS | Jul 14, 2026, 05:42 PM UTC
L
DOJ Expands Antitrust Probe Into Claritev
() -- The US Justice Department recently sent civil investigative demands, which are similar to subpoenas, to lawyers for a group of hospitals and doctor groups suing Claritev (CTEV) for alleged antitrust violations, Blo
EQUITY | Jul 14, 2026, 05:18 PM UTC
L
DOJ expands Claritev antitrust investigation, Bloomberg reports
DOJ expands Claritev antitrust investigation, Bloomberg reports
EQUITY | Jul 14, 2026, 05:02 PM UTC
M
CTEV: DOJ Closes Probe
Claritev confirms the DOJ has closed its antitrust grand jury probe and the company is not under criminal investigation
REGULATION | Jun 22, 2026, 08:10 PM UTC